4//SEC Filing
Mor George Adi 4
Accession 0001178913-22-004098
CIK 0001534248other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:56 PM ET
Size
12.0 KB
Accession
0001178913-22-004098
Insider Transaction Report
Form 4
Mor George Adi
DirectorChief Executive Officer10% Owner
Transactions
- Sale
American Depositary Shares
2022-11-16$2.08/sh−324,775$677,091→ 324,775 total - Award
Option to Purchase American Depositary Shares
2018-03-15+131,698→ 131,698 totalExercise: $1.49Exp: 2028-03-15→ American Depositary Shares (131,698 underlying) - Sale
American Depositary Shares
2022-11-16$2.08/sh−257,248$536,311→ 257,247 total(indirect: By Spouse) - Award
Option to Purchase American Depositary Shares
2016-10-28+33,725→ 33,725 total(indirect: By Spouse)Exercise: $0.80Exp: 2026-10-27→ American Depositary Shares (33,725 underlying)
Footnotes (5)
- [F1]Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- [F2]The reported price in Column 4 is a weighted average price pursuant to the share purchase agreement between Adi Mor, Kobi George, and the Issuer, as disclosed in the Issuer's Form 8-K filed with the Securities and Exchange Commission on November 16, 2022.
- [F3]No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- [F4]These options have vested and are exercisable as of the date hereof.
- [F5]These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
Documents
Issuer
Chemomab Therapeutics Ltd.
CIK 0001534248
Entity typeother
Related Parties
1- filerCIK 0001851069
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:56 PM ET
- Size
- 12.0 KB